Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With Higher-risk MDS

Conditions: Myelodysplastic Syndromes Interventions: Biological: Unrelated Umbilical Cord Blood; Drug: Venetoclax; Drug: Decetabine; Drug: Azacitidine Sponsors: Anhui Provincial Hospital Recruiting

https://clinicaltrials.gov/study/NCT06109064

Source: ClinicalTrials.gov - October 31, 2023 Category: Research Source Type: clinical trials

More News: Hospitals | Myelodysplastic Syndrome | Research